Myriad Genetics Inc (NASDAQ:MYGN)

Wednesday’s trading has closed, but MYGN is being traded in the after-hours session. After-Hours quote »
33.67
Delayed Data
As of 4:00pm ET
 -0.87 / -2.52%
Today’s Change
31.56
Today|||52-Week Range
41.64
-1.15%
Year-to-Date

Today’s Trading

Previous close34.54
Today’s open32.98
Day’s range32.00 - 33.86
Volume1,788,149
Average volume (3 months)719,705
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 05/06/2015

Growth & Valuation

Earnings growth (last year)+27.12%
Earnings growth (this year)-37.26%
Earnings growth (next 5 years)+14.19%
Revenue growth (last year)+26.92%
P/E ratio23.3
Price/Sales3.31
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+0.60+0.61%
ANACAnacor Pharmaceutica...+1.05+1.89%
--COSMO Pharmaceutical...+1.20+0.75%
RAREUltragenyx Pharmaceu...+1.87+2.99%
Data as of 4:00pm ET, 05/06/2015

Financials

Last reporting dateMay 6, 2015
EPS forecast (this quarter)$0.39
Annual revenue (last year)$778.2M
Annual profit (last year)$176.2M
Net profit margin22.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Peter D. Meldrum
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers